Hyperhidrosis Treatment Market 2021 Growth Drivers, Business Strategies and Future Prospects 2025: Allergan, Brickell Biotech, Dermira, GlaxoSmithKline, Revance Therapeutics, Ulthera, TheraVida, Sientra

Hyperhidrosis Treatment Market Report provides detailed analysis of Growth Factors of the market as well as it gives an analysis of the Market size, Latest trends, SWOT Analysis by Regions and Forecasted market research data until 2025. The Hyperhidrosis Treatment market report has studied key opportunities in the market and influencing factors which are useful to the business. The report also maps the qualitative and quantitative impact of various market factors like macro-economic indicators, PPP, Epidemiological data, Insurance scenario and patent and IP information, Government Policies and business regulations along market attractiveness as per segments.

The hyperhidrosis treatment market studied is anticipated to grow with a CAGR of 6.2% during the forecast period.

Get Sample Copy Of This Report + All Related Graphs (Covid-19 Update):

https://www.marketinsightsreports.com/reports/10192357657/hyperhidrosis-treatment-market-growth-trends-and-forecasts-2020-2025/inquiry?source=OpenPr&Mode=12                       

The report presents the market competitive landscape and a corresponding detailed analysis of the major vendor/key players in the market. Top Companies in the Global Hyperhidrosis Treatment Market: Allergan, Brickell Biotech, Dermira, GlaxoSmithKline, Revance Therapeutics, Ulthera, TheraVida, Sientra. and others.

Industry News and Developments:

Brickell Biotech Reports Results from U.S. Phase 3 Open-Label, Long-Term Safety Study on Chronic Use of Sofpironium Bromide Gel as a Potential Treatment for Primary Axillary Hyperhidrosis

BOULDER, Colo., April 23, 2021 -- Brickell Biotech, Inc. (“Brickell” or the “Company”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced results from its Phase 3 open-label, long-term safety study (“ARGYLE” or “LTSS”), which were also presented today in a late-breaking oral presentation at the American Academy of Dermatology’s (“AAD”) 2021 Virtual Meeting Experience (“VMX”). The ARGYLE study assessed the long-term safety and efficacy of topical, once-daily treatment with sofpironium bromide gel, 5% and 15% for 48 weeks in patients nine years and older with primary axillary hyperhidrosis, or excessive underarm sweating.

Brickell Biotech Announces Publication of Japan Phase 3 Long-Term Safety and Efficacy Study Results for Sofpironium Bromide Gel, 5% (ECCLOCK®) in the Journal of Dermatology

BOULDER, Colo., June 01, 2021 -- Brickell Biotech, Inc. (“Brickell”) (Nasdaq: BBI), a clinical-stage pharmaceutical company focused on developing innovative and differentiated prescription therapeutics for the treatment of debilitating skin diseases, today announced that the results from the Phase 3 long-term safety and efficacy study conducted in Japan by its development partner, Kaken Pharmaceutical Co., Ltd. (“Kaken”) were published in the peer-reviewed Journal of Dermatology1.

The paper, entitled “A phase III, 52-week, open-label study to evaluate the safety and efficacy of 5% sofpironium bromide (BBI-4000) gel in Japanese patients with primary axillary hyperhidrosis,” is available online in English at the Wiley Online Library

Kaken and Brickell first announced the release of the Japan pivotal Phase 3 study results in June 2020 and this is the first release of these long-term safety and efficacy results. Kaken received regulatory approval to manufacture and market ECCLOCK® in Japan for the treatment of primary axillary hyperhidrosis in September 2020 and launched commercial sales in November 2020. Japan is the first country to approve sofpironium bromide, which also marks the first approval of a topical prescription product for the treatment of primary axillary hyperhidrosis in Japan.

Journey Medical to acquire hyperhidrosis treatment Qbrexza

April 01, 2021: Journey Medical will acquire Qbrexza from Dermira, according to a press release. Qbrexza (glycopyrronium), an FDA-approved cloth towelette used as a topical treatment for primary axillary hyperhidrosis in adults and adolescents, generated $24 million in U.S. net sales in 2020, the release said. Journey Medical, a partner company of Fortress Biotech, and Dermira, a wholly owned subsidiary of Eli Lilly and Company, will complete the transaction in the second quarter.

Key Market Trends

According to JAAD (Journal of the American Academy of Dermatology), 2.8% of the American population suffers from Hyperhidrosis. As the incidence of this disease increases, significant players are interested in investing in its treatment market. However, the results of the therapeutics are for very less time and, the need to repeat the treatments, constrain the market.

Primary hyperhidrosis Segment is Expected to Hold the Largest Market Share in the Hyperhidrosis Treatment Market

Primary hyperhidrosis is a disease characterized by excessive sweating localized in certain body regions particularly palms, feet, and underarms. Primary hyperhidrosis treatments have been accounted for a significant share of the market and the share is expected to increase in the coming years. The advanced therapies are available in varied sections which involve mainly, topical and surgical. The choice of treatment depends on the severity of the condition and affordability.

North America Dominates the Market and Expected to do Same in the Forecast Period

North America is expected to dominate the overall hyperhidrosis treatment market throughout the forecast period. The factors such as the rising incidence of secondary hyperhidrosis increase the market growth in the region. Among the developed countries the United States has the maximum number of patients suffering from hyperhidrosis.

The current disease trends in the United States suggest that the number of cases of hyperhidrosis will increase at a rapid pace. Also, presence of favorable reimbursement policies are expected to boost the growth of the market.

Competitive Landscape

The hyperhidrosis treatment market is moderately consolidated and consists of several major players. In terms of market share, few of the major players are currently dominating the market. And some prominent players are vigorously making acquisitions with the other companies to consolidate their market positions across the globe (Sientra acquired Miramar). Some of the market players are Allergan, Brickell Biotech, Dermira, GlaxoSmithKline, Revance Therapeutics, Ulthera, TheraVida, Sientra.

Buy The Report:
https://www.marketinsightsreports.com/report/purchase/10192357657?mode=su?source=OpenPr&Mode=12                             

Regional Analysis For Hyperhidrosis Treatment Market:

For comprehensive understanding of market dynamics, the global Hyperhidrosis Treatment market is analyzed across key geographies namely:

North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Each of these regions is analyzed on basis of market findings across major countries in these regions for a macro-level understanding of the market.

Hyperhidrosis Treatment Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger and acquisitions along with trending innovation and business policies are reviewed in the report. The report contains basic, secondary and advanced information pertaining to the Market global status and trend, market size, share, growth, trends analysis, segment and forecasts from 2021–2027.                 

Key Points of Hyperhidrosis Treatment Market Table of Contents:

-Market Overview: The report begins with this section where a product overview and key content on the product and application segments of the global Halal Foods market are provided. The highlights of the segmentation study include price, revenue, sales, sales growth rate, and market share by product.

-Competition by company: Here we analyze the competition of the global Hyperhidrosis Treatment market, by company price, revenue, sales and market share, market share, competitive landscape, and latest trends, mergers, expansions, acquisitions, and market share of top companies.

-Company Profile and Sales Data: As the name suggests, this section provides sales data and useful information about the business of key players in the global Hyperhidrosis Treatment market. It describes the key businesses of gross margin, price, revenue, products and specifications, types, applications, competitors, manufacturing base, and key players operating in the global Hyperhidrosis Treatment market.

-Market Forecast: Here the report provides a full forecast for the global Hyperhidrosis Treatment market by product, application, and region. It also provides global sales and revenue forecasts for all years in the forecast period.

-Research Results and Conclusion: One of the last sections of the report where analyst findings and findings are provided.

For More Information On This Report, Please Visit: https://www.marketinsightsreports.com/reports/10192357657/hyperhidrosis-treatment-market-growth-trends-and-forecasts-2020-2025?source=OpenPr&Mode=12                    

Due to the onset of COVID-19 pandemic, several economies across the world have experienced harsh economic downturn. The industrialists across North America, Europe, Asia Pacific, Latin America and Middle East and Africa were facing problems due to changing preferences of the customers and demand fluctuation. The market research report covers pre-Covid-19 data for the Hyperhidrosis Treatment market in years 2018 and 2020. Further, the report also covers forecast Covid-19 data from 2021 to 2025, which provides future outlook of the market for the manufacturers and suppliers.

Browse Related Reports:

Axillary Hyperhidrosis Treatment Market:  

https://www.marketinsightsreports.com/reports/11102449776/global-axillary-hyperhidrosis-treatment-market-growth-status-and-outlook-2020-2025?source=OpenPr&Mode=12                          

Palmer Hyperhidrosis Treatment Market:

https://www.marketinsightsreports.com/reports/01301805177/global-palmer-hyperhidrosis-treatment-market-size-status-and-forecast-2020-2026?source=OpenPr&Mode=12                              

Energy Based Device In Hyperhidrosis Market:

https://www.marketinsightsreports.com/reports/05072878314/global-energy-based-device-in-hyperhidrosis-sales-market-report-2021?source=OpenPr&Mode=12                      

Customization Of The Report:

MarketInsightsReports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.     

If you have any questions about any of our “Hyperhidrosis Treatment market report” or would like to schedule a personalized free demo of Hyperhidrosis Treatment market report, please do not hesitate to contact me at irfan@marketinsightsreports.com.

Best wishes,

Irfan Tamboli

Head of Sales Operations

Market Insights Reports

Tel: + 1704 266 3234 | +91-750-707-8687

Email: sales@marketinsightsreports.com | irfan@marketinsightsreports.com

About Us:

MarketInsightsReports provides syndicated market research on industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. MarketInsightsReports provides Global and regional market intelligence coverage, a 360-degree market view which includes statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

This release was published on openPR.